Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Calabrò

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Critical Reviews in Oncology/Hematology|May 27, 2006
Current therapies and advances in the treatment of pancreatic cancerAndrea Mancuso, Fabio Calabrò, Cora N Sternberg
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2023
Primary and acquired resistance to first-line therapy for clear cell renal cell carcinomaSerena Astore, Giulia Baciarello, Linda Cerbone, et al.
Current Treatment Options in Oncology|January 27, 2016
Chemotherapy for Muscle-Invasive Bladder CancerPatrizia Trenta, Fabio Calabrò, Linda Cerbone, et al.
Chemotherapy|December 18, 2024
Therapeutic Drug Monitoring, Population Pharmacokinetics Models, and External Validation of High-Dose Methotrexate in Pediatric Acute Lymphoblastic LeukemiaNatalia Maximova, Pasquale Fabio Calabrò, Alice Cangialosi, et al.
Spine|October 30, 2010
Development of the Italian version of the revised Scoliosis Research Society-22 Patient Questionnaire, SRS-22r-I: cross-cultural adaptation, factor analysis, reliability, and validityMarco Monticone, Paola Baiardi, David Calabrò, et al.
Current Oncology Reports|March 6, 2024
Metronomic Chemotherapy in Elderly PatientsArianna Bandini, Pasquale Fabio Calabrò, Marta Banchi, et al.
Cancer Letters|March 13, 2023
Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?Gianfranco Natale, Elisabetta Fini, Pasquale Fabio Calabrò, et al.
Critical Reviews in Oncology/Hematology|December 21, 2025
A daily clinical practice decision-making overview for the present metastatic renal cell carcinoma (mRCC) management landscapeSergio Bracarda, Fabio Calabrò, Ugo De Giorgi, et al.
Neuromuscular Disorders : NMD|May 11, 2020
Immune checkpoint inhibitors (ICIs)-related ocular myositisMatteo Garibaldi, Fabio Calabrò, Gioia Merlonghi, et al.
BJU International|February 12, 2026
Cytoreductive nephrectomy in the era of immune-checkpoint inhibitors: back to the future?Rocco Simone Flammia, Riccardo Campi, Eugenio Bologna, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Critical Reviews in Oncology/Hematology|May 27, 2006
Current therapies and advances in the treatment of pancreatic cancerAndrea Mancuso, Fabio Calabrò, Cora N Sternberg
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2023
Primary and acquired resistance to first-line therapy for clear cell renal cell carcinomaSerena Astore, Giulia Baciarello, Linda Cerbone, et al.
Current Treatment Options in Oncology|January 27, 2016
Chemotherapy for Muscle-Invasive Bladder CancerPatrizia Trenta, Fabio Calabrò, Linda Cerbone, et al.
Chemotherapy|December 18, 2024
Therapeutic Drug Monitoring, Population Pharmacokinetics Models, and External Validation of High-Dose Methotrexate in Pediatric Acute Lymphoblastic LeukemiaNatalia Maximova, Pasquale Fabio Calabrò, Alice Cangialosi, et al.
Spine|October 30, 2010
Development of the Italian version of the revised Scoliosis Research Society-22 Patient Questionnaire, SRS-22r-I: cross-cultural adaptation, factor analysis, reliability, and validityMarco Monticone, Paola Baiardi, David Calabrò, et al.
Current Oncology Reports|March 6, 2024
Metronomic Chemotherapy in Elderly PatientsArianna Bandini, Pasquale Fabio Calabrò, Marta Banchi, et al.
Cancer Letters|March 13, 2023
Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?Gianfranco Natale, Elisabetta Fini, Pasquale Fabio Calabrò, et al.
Critical Reviews in Oncology/Hematology|December 21, 2025
A daily clinical practice decision-making overview for the present metastatic renal cell carcinoma (mRCC) management landscapeSergio Bracarda, Fabio Calabrò, Ugo De Giorgi, et al.
Neuromuscular Disorders : NMD|May 11, 2020
Immune checkpoint inhibitors (ICIs)-related ocular myositisMatteo Garibaldi, Fabio Calabrò, Gioia Merlonghi, et al.
BJU International|February 12, 2026
Cytoreductive nephrectomy in the era of immune-checkpoint inhibitors: back to the future?Rocco Simone Flammia, Riccardo Campi, Eugenio Bologna, et al.
Pageof 8